Ionis Pharmaceuticals Inc annual free cash flow for fiscal TTM was -$562 million, a decrease of 75.6% from -$320 million in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Free Cash Flow (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | ($562M) | ($320M) | ($546M) | ($336M) | ($294M) | $13M | ($5M) | $309M | $585M | $136M | ($124M) | $9M | ($5M) | $58M | ($3M) | ($126M) | ($81M) | ($125M) | $195M | $31M | ($56M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Free Cash Flow (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | $547M | ($815M) | ($159M) | ($135M) | $137M | ($163M) | ($142M) | ($124M) | ($140M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More IONS metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Shares Outstanding
All IONS financial statements → Interactive IONS charts →
About TickerBase · Data methodology & sources · Privacy · Terms